Second cancer risk, concomitant exposures and IRMER(2000)

被引:33
作者
Aird, EGA
机构
关键词
D O I
10.1259/bjr/56613233
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:983 / 985
页数:3
相关论文
共 10 条
[1]  
[Anonymous], 2000, Report to the General Assembly, VII
[2]   Active minimisation of radiation scatter during breast radiotherapy: Management implications for young patients with good-prognosis primary neoplasms [J].
Epstein, RJ ;
Kelly, SA ;
Cook, M ;
Bateman, A ;
Paddick, I ;
Kam, KC ;
Dunn, P ;
Hanham, IW ;
Dale, RG ;
Price, PM .
RADIOTHERAPY AND ONCOLOGY, 1996, 40 (01) :69-74
[3]   Radiation-induced second cancers: The impact of 3D-CRT and IMRT [J].
Hall, EJ ;
Wuu, CS .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 56 (01) :83-88
[4]   Second cancers following radiotherapy: a suggested common dosimetry framework for therapeutic and concomitant exposures [J].
Harrison, RM .
BRITISH JOURNAL OF RADIOLOGY, 2004, 77 (924) :986-990
[5]  
Institute of Physics and Engineering in Medicine, 2002, MED DENT GUID NOT GO
[6]   Motes and beams: some observations on an IR(ME)R inspection in radiotherapy [J].
Munro, AJ .
BRITISH JOURNAL OF RADIOLOGY, 2004, 77 (916) :273-275
[7]  
*RCR, 1996, GUID RET DESTR NHS M
[8]   Assessment of effective dose from concomitant exposures required in verification of the target volume in radiotherapy [J].
Waddington, SP ;
McKenzie, AL .
BRITISH JOURNAL OF RADIOLOGY, 2004, 77 (919) :557-561
[9]  
2003, NHSBSP PUBLICATION, V54
[10]  
2000, IONISING RAD MED EXP